Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Recruiting · NCT06833632 · Observational (researchers observe without assigning treatment) · Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View the official record on ClinicalTrials.gov →What this trial is about
The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- obtaining voluntary written informed consent
- diagnosis of NSCLC
- clinical stage I-IIA cN0
- Candidates for surgical resection
Exclusion criteria
- Pregnancy
- Induction therapy for pulmonary neoplasia
- Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery
- Any previous surgery for lung cancer
- Patients with other active neoplasms
- Infiltration of the chest wall
Where it is running
1 location listed.
- IRCCS - Azienda Ospedaliero Universitaria di Bologna - Bologna, Emilia-Romagna, Italy